THTX - Theratechnologies Inc.
IEX Last Trade
1.285
0.005 0.389%
Share volume: 4,379
Last Updated: Fri 30 Aug 2024 09:59:25 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.28
0.01
0.39%
Summary score
6%
Profitability
0%
Dept financing
16%
Liquidity
44%
Performance
0%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 31-Dec-2015 - 31-Dec-2019
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-7.81%
Return on assets
-1.91%
Return on sales
-13.43%
Return on invested capital
-38.68%
Total debt ratio
56.15%
Debt ratio change over timeo
1.75%
Current Ratio
2.15%
Quick Ratio
1.67%
Cash Position Ratio
0.64%
Short-term ratios 31-Dec-2018 - 31-Dec-2019
The data are presented for the financials results of the quarters of the last year.
Return on equity
-11.29%
Return on assets
-1.85%
Return on sales
-13.21%
Return on invested capital
-48.76%
Total debt ratio
73.36%
Debt ratio change over timeo
-7.34%
Current Ratio
2.43%
Quick Ratio
1.95%
Cash Position Ratio
1.11%
Last quarter ratios 31-Dec-2019
The data are presented for the financials results of the last quarter.
Return on equity
-25.99%
Return on assets
-4.59%
Return on sales
-32.91%
Return on invested capital
-152.6%
Total debt ratio
78.87%
Debt ratio change over time
-6.69%
Current Ratio
2.05%
Quick Ratio
1.49%
Cash Position Ratio
0.77%
Performance ratios (change over 4 years) 31-Dec-2015 - 31-Dec-2019
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-96.45%
Return on assets
-90.69%
Return on sales
-35%
Return on invested capital
-76.16%
Total debt ratio
174.68%
Debt ratio change over time
1.75%
Current Ratio
15.44%
Quick Ratio
12.18%
Cash Position Ratio
4.62%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | THTX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -7.81% | 3.38% | 10.1% | 6.09% |
| Return on assets | -1.91% | 3.79% | 3.51% | 5.38% |
| Return on sales | -13.43% | 33.46% | 42.92% | 33.01% |
| Return on invested capital | -38.68% | 4.88% | 8.3% | 11.96% |
| Profitability | 0% | 56% | 84% | 84% |
| Total debt ratio | 56.15% | 100.22% | 71.21% | 29.5% |
| Debt ratio change over time | 1.75% | 14.95% | 5.12% | 1.7% |
| Dept financing | 17% | 50% | 26% | 10% |
| Current Ratio | 2.43% | 1.56% | 2.5% | 4.04% |
| Quick Ratio | 1.95% | 1.45% | 2.22% | 3.29% |
| Cash Position Ratio | 1.11% | 0.97% | 0.66% | 1.72% |
| Liquididy | 38% | 31% | 61% | 70% |
| Short-term ratios | THTX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -11.29% | -24.18% | 18.55% | 5.09% |
| Return on assets | -1.85% | 4.92% | 3.95% | 4% |
| Return on sales | -13.21% | 37.6% | 41.32% | 27.89% |
| Return on invested capital | -48.76% | 7.93% | 10.38% | 10.86% |
| Profitability | 0% | 66% | 94% | 69% |
| Total debt ratio | 73.36% | 112.95% | 82.58% | 25.55% |
| Debt ratio change over time | -7.34% | 16.62% | 5.88% | 2.04% |
| Dept financing | 16% | 50% | 27% | 9% |
| Current Ratio | 2.43% | 1.56% | 2.5% | 4.04% |
| Quick Ratio | 1.95% | 1.45% | 2.22% | 3.29% |
| Cash Position Ratio | 1.11% | 0.97% | 0.66% | 1.72% |
| Liquididy | 46% | 35% | 42% | 75% |